Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation. [electronic resource]
Producer: 20000105Description: 985-91 p. digitalISSN:- 0009-7330
- 8-Bromo Cyclic Adenosine Monophosphate -- pharmacology
- Blotting, Western
- CDC2-CDC28 Kinases
- Cell Cycle -- drug effects
- Cells, Cultured
- Cyclic AMP -- pharmacology
- Cyclic GMP -- analogs & derivatives
- Cyclin D1 -- antagonists & inhibitors
- Cyclin-Dependent Kinase 2
- Cyclin-Dependent Kinase 4
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclin-Dependent Kinases -- antagonists & inhibitors
- Cyclins -- physiology
- Enzyme Activation -- drug effects
- Humans
- Muscle, Smooth, Vascular -- cytology
- Phosphorylation -- drug effects
- Protein Processing, Post-Translational -- drug effects
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Proto-Oncogene Proteins
- Umbilical Arteries
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.